Volume 8, Issue 4 pp. 305-310
Article
Full Access

Age-associated memory impairment: Diagnostic and treatment issues

Andrew Barker

Andrew Barker

Research Fellow, Research Institute for the Care of the Elderly, St Martin's Hospital, Bath BA2 5RP, UK

Search for more papers by this author
Roy Jones

Roy Jones

Director, Research Institute for the Care of the Elderly, St Martin's Hospital, Bath BA2 5RP, UK

Search for more papers by this author
First published: April 1993
Citations: 17

Abstract

There has been an enormous increase in research to identify potential pharmacological treatments for cognitive impairment in elderly people. Currently, well over 150 such compounds are under development by the pharmaceutical industry. However, among those who are potential targets for such treatment are many who suffer from relatively mild disorder, where the distinction from both dementia and ‘normality’ is not clear. These people include those described as suffering from benign senescent forgetfulness and age-associated memory impairment. This article discusses principles of diagnosis and treatment in this area with particular reference to age-associated memory impairment. For ethical, practical and economic reasons it is essential that these issues are examined thoroughly before any apparent breakthrough in therapy.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.